ABOUT US
Yichang Tianren Pharmaceutical Co., Ltd.
Yichang Tianren Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) was established in 2004 and is a controlling subsidiary of Yichang Renfu Pharmaceutical. As a high-tech enterprise, the Company focuses on the research and development, production, and sales of chemical APIs and pharmaceutical intermediates. The Company currently employs over 160 staff members, occupies a site of 34,354 square meters, and has a total floor area of 15,765 square meters.
National High-Tech Enterprise
It has obtained national high-tech enterprise certification and possesses advanced R&D and manufacturing capabilities.
Hubei Provincial Enterprise Technology Center
It operates a provincial-level enterprise technology center and is committed to innovative drug research and development.
Specialized, Refined, Distinctive, and Innovative Little Giant
Being included on Hubei Province’s list of “Specialized, Refined, Distinctive, and Innovative” Little Giant Enterprises underscores our competitive edge in specialization.
Technology-based small and medium-sized enterprises
Recognized as a technology-based small and medium-sized enterprise, we continue to drive technological advancement in the industry.
OUR PRODUCTS
Key Products
Active pharmaceutical ingredient
Active pharmaceutical ingredients used in the manufacture of various drugs, including chemical APIs and traditional Chinese medicinal materials, must comply with stringent pharmacopoeial standards.
Chemical raw materials or chemical products used in pharmaceutical synthesis processes.
ENTERPRISE QULIFICATIONS
Enterprise Qualifications
NEWS CENTER
News Updates
Consultation Service Hotline
Address: No. 509, East Lin Road, Bio-Industrial Park, High-tech Zone, Yichang City, Hubei Province, China
International Marketing Department
Contact: Vivian Guo
Email: Vivian.guo@tianrenpharm.com
Phone: 86-15997560212
WhatsApp: +86-15997560212
Website Development:China Enterprise Dynamics Yichang right of privacy
This website supports both IPv4 and IPv6 bidirectional access.